186 related articles for article (PubMed ID: 31468366)
1.
Pálfy G; Vida I; Perczel A
Biomol NMR Assign; 2020 Apr; 14(1):1-7. PubMed ID: 31468366
[TBL] [Abstract][Full Text] [Related]
2. NMR
Yuan C; Hansen AL; Bruschweiler-Li L; Brüschweiler R
Biomol NMR Assign; 2024 Jun; 18(1):7-13. PubMed ID: 37948018
[TBL] [Abstract][Full Text] [Related]
3. NMR
Sharma AK; Lee SJ; Zhou M; Rigby AC; Townson SA
Biomol NMR Assign; 2019 Apr; 13(1):227-231. PubMed ID: 30798456
[TBL] [Abstract][Full Text] [Related]
4. NMR
Sharma AK; Lee SJ; Rigby AC; Townson SA
Biomol NMR Assign; 2018 Oct; 12(2):269-272. PubMed ID: 29721757
[TBL] [Abstract][Full Text] [Related]
5. Excited-state observation of active K-Ras reveals differential structural dynamics of wild-type versus oncogenic G12D and G12C mutants.
Hansen AL; Xiang X; Yuan C; Bruschweiler-Li L; Brüschweiler R
Nat Struct Mol Biol; 2023 Oct; 30(10):1446-1455. PubMed ID: 37640864
[TBL] [Abstract][Full Text] [Related]
6. Conformational Dynamics Allows Sampling of an "Active-like" State by Oncogenic K-Ras-GDP.
Grudzien P; Jang H; Leschinsky N; Nussinov R; Gaponenko V
J Mol Biol; 2022 Sep; 434(17):167695. PubMed ID: 35752212
[TBL] [Abstract][Full Text] [Related]
7. The Structural Basis of Oncogenic Mutations G12, G13 and Q61 in Small GTPase K-Ras4B.
Lu S; Jang H; Nussinov R; Zhang J
Sci Rep; 2016 Feb; 6():21949. PubMed ID: 26902995
[TBL] [Abstract][Full Text] [Related]
8. GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site.
Lu S; Banerjee A; Jang H; Zhang J; Gaponenko V; Nussinov R
J Biol Chem; 2015 Nov; 290(48):28887-900. PubMed ID: 26453300
[TBL] [Abstract][Full Text] [Related]
9. High-frequency 94 GHz ENDOR characterization of the metal binding site in wild-type Ras x GDP and its oncogenic mutant G12V in frozen solution.
Bennati M; Hertel MM; Fritscher J; Prisner TF; Weiden N; Hofweber R; Spörner M; Horn G; Kalbitzer HR
Biochemistry; 2006 Jan; 45(1):42-50. PubMed ID: 16388579
[TBL] [Abstract][Full Text] [Related]
10. In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C.
Hunter JC; Gurbani D; Ficarro SB; Carrasco MA; Lim SM; Choi HG; Xie T; Marto JA; Chen Z; Gray NS; Westover KD
Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8895-900. PubMed ID: 24889603
[TBL] [Abstract][Full Text] [Related]
11. 1H, 15N and 13C backbone assignments of GDP-bound human H-Ras mutant G12V.
Amin N; Chiarparin E; Coyle J; Nietlispach D; Williams G
Biomol NMR Assign; 2016 Apr; 10(1):121-3. PubMed ID: 26373425
[TBL] [Abstract][Full Text] [Related]
12. Mutational landscape of K-Ras substitutions at 12th position-a systematic molecular dynamics approach.
S UK; R B; D TK; Doss CGP; Zayed H
J Biomol Struct Dyn; 2022 Mar; 40(4):1571-1585. PubMed ID: 33034275
[TBL] [Abstract][Full Text] [Related]
13. ¹H, ¹³C and ¹⁵N resonance assignment for the human K-Ras at physiological pH.
Vo U; Embrey KJ; Breeze AL; Golovanov AP
Biomol NMR Assign; 2013 Oct; 7(2):215-9. PubMed ID: 22886485
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of oncogenic mutations G12C, G12V, G13D, and Q61H on local conformations and dynamics of K-Ras.
Vatansever S; Erman B; Gümüş ZH
Comput Struct Biotechnol J; 2020; 18():1000-1011. PubMed ID: 32373288
[TBL] [Abstract][Full Text] [Related]
15. Distinct dynamics and interaction patterns in H- and K-Ras oncogenic P-loop mutants.
Sayyed-Ahmad A; Prakash P; Gorfe AA
Proteins; 2017 Sep; 85(9):1618-1632. PubMed ID: 28498561
[TBL] [Abstract][Full Text] [Related]
16. Revealing the mechanism of action of a first-in-class covalent inhibitor of KRASG12C (ON) and other functional properties of oncogenic KRAS by
Sharma AK; Pei J; Yang Y; Dyba M; Smith B; Rabara D; Larsen EK; Lightstone FC; Esposito D; Stephen AG; Wang B; Beltran PJ; Wallace E; Nissley DV; McCormick F; Maciag AE
J Biol Chem; 2024 Feb; 300(2):105650. PubMed ID: 38237681
[TBL] [Abstract][Full Text] [Related]
17. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.
Ostrem JM; Peters U; Sos ML; Wells JA; Shokat KM
Nature; 2013 Nov; 503(7477):548-51. PubMed ID: 24256730
[TBL] [Abstract][Full Text] [Related]
18. Structure of the metal-water complex in Ras x GDP studied by high-field EPR spectroscopy and 31P NMR spectroscopy.
Rohrer M; Prisner TF; Brügmann O; Käss H; Spoerner M; Wittinghofer A; Kalbitzer HR
Biochemistry; 2001 Feb; 40(7):1884-9. PubMed ID: 11329253
[TBL] [Abstract][Full Text] [Related]
19. Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression.
Al-Mulla F; Milner-White EJ; Going JJ; Birnie GD
J Pathol; 1999 Mar; 187(4):433-8. PubMed ID: 10398103
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for conformational dynamics of GTP-bound Ras protein.
Shima F; Ijiri Y; Muraoka S; Liao J; Ye M; Araki M; Matsumoto K; Yamamoto N; Sugimoto T; Yoshikawa Y; Kumasaka T; Yamamoto M; Tamura A; Kataoka T
J Biol Chem; 2010 Jul; 285(29):22696-705. PubMed ID: 20479006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
